重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2014年
32期
4311-4313
,共3页
钟益萍%米向斌%张堂德%孙乐栋
鐘益萍%米嚮斌%張堂德%孫樂棟
종익평%미향빈%장당덕%손악동
红斑狼疮,系统性%流式细胞术%CD4+CD25+T细胞%白芍总苷
紅斑狼瘡,繫統性%流式細胞術%CD4+CD25+T細胞%白芍總苷
홍반랑창,계통성%류식세포술%CD4+CD25+T세포%백작총감
lupus erythematosus,systemic%flow cytometry%CD4+CD25+ T cells%TGP
目的:探讨白芍总苷(TGP)辅助治疗系统性红斑狼疮(SLE)对患者外周血CD4+CD25+T细胞表达水平的影响。方法采用流式细胞术检测健康对照组、常规组、TGP组外周血CD4+CD25+T细胞比率。结果SLE患者CD4+CD25+T细胞表达率为(6.15±1.21)%,健康对照组CD4+CD25+T细胞表达率为(12.30±1.78)%。活动期SLE患者与健康对照组CD4+CD25+T细胞表达率比较,差异有统计学意义(t=22.03,P<0.05);常规组治疗前后外周血CD4+CD25+T细胞的表达水平差异有统计学意义(t=-12.30,P<0.05);TGP组治疗前后外周血CD4+CD25+T细胞的表达水平差异也有统计学意义(t=-16.68,P<0.05)。常规组外周血CD4+CD25+T细胞的表达水平为(9.34±1.37)%,TGP组外周血CD4+CD25+T细胞的表达水平为(11.49±1.14)%,两组差异有统计学意义(t=-6.46,P<0.05)。结论活动期SLE患者CD4+CD25+T细胞表达率水平显著低于健康对照组;SLE患者经过TGP辅助治疗后CD4+CD25+T细胞表达率显著提高。TGP治疗可能作用于CD4+CD25+T细胞。
目的:探討白芍總苷(TGP)輔助治療繫統性紅斑狼瘡(SLE)對患者外週血CD4+CD25+T細胞錶達水平的影響。方法採用流式細胞術檢測健康對照組、常規組、TGP組外週血CD4+CD25+T細胞比率。結果SLE患者CD4+CD25+T細胞錶達率為(6.15±1.21)%,健康對照組CD4+CD25+T細胞錶達率為(12.30±1.78)%。活動期SLE患者與健康對照組CD4+CD25+T細胞錶達率比較,差異有統計學意義(t=22.03,P<0.05);常規組治療前後外週血CD4+CD25+T細胞的錶達水平差異有統計學意義(t=-12.30,P<0.05);TGP組治療前後外週血CD4+CD25+T細胞的錶達水平差異也有統計學意義(t=-16.68,P<0.05)。常規組外週血CD4+CD25+T細胞的錶達水平為(9.34±1.37)%,TGP組外週血CD4+CD25+T細胞的錶達水平為(11.49±1.14)%,兩組差異有統計學意義(t=-6.46,P<0.05)。結論活動期SLE患者CD4+CD25+T細胞錶達率水平顯著低于健康對照組;SLE患者經過TGP輔助治療後CD4+CD25+T細胞錶達率顯著提高。TGP治療可能作用于CD4+CD25+T細胞。
목적:탐토백작총감(TGP)보조치료계통성홍반랑창(SLE)대환자외주혈CD4+CD25+T세포표체수평적영향。방법채용류식세포술검측건강대조조、상규조、TGP조외주혈CD4+CD25+T세포비솔。결과SLE환자CD4+CD25+T세포표체솔위(6.15±1.21)%,건강대조조CD4+CD25+T세포표체솔위(12.30±1.78)%。활동기SLE환자여건강대조조CD4+CD25+T세포표체솔비교,차이유통계학의의(t=22.03,P<0.05);상규조치료전후외주혈CD4+CD25+T세포적표체수평차이유통계학의의(t=-12.30,P<0.05);TGP조치료전후외주혈CD4+CD25+T세포적표체수평차이야유통계학의의(t=-16.68,P<0.05)。상규조외주혈CD4+CD25+T세포적표체수평위(9.34±1.37)%,TGP조외주혈CD4+CD25+T세포적표체수평위(11.49±1.14)%,량조차이유통계학의의(t=-6.46,P<0.05)。결론활동기SLE환자CD4+CD25+T세포표체솔수평현저저우건강대조조;SLE환자경과TGP보조치료후CD4+CD25+T세포표체솔현저제고。TGP치료가능작용우CD4+CD25+T세포。
Objective to investigate the effect of TGP assisted treatment of SLE on the expression of CD4+CD25+ T in patient peripheral blood .Methods flow cytometry was used to detect the peripheral blood CD4+ CD25+ T cells in healthy group ,routine group and TGP group .Results The expression rate of CD4+CD25+ T cells in SLE patients was (6 .15 ± 1 .21)% ,and that of the healthy controls was (12 .30 ± 1 .78)% .The expression rate of CD4+CD25+ T cells in active SLE patients and healthy controls were significantly different (t=22 .03 ,P<0 .05) .In the routine group ,the expression rate of peripheral blood CD4+CD25+ T cells before and after treatment were significantly different (t= 12 .30 ,P<0 .05);in the TGP group ,the expression rate of peripheral blood CD4+ CD25+ T cells before and after treatment were significantly different ,too (t=16 .68 ,P<0 .05) .The expression rate of periph‐eral blood CD4+CD25+ T cells in routine group and TGP group were (9 .34 ± 1 .37)% and (11 .49 ± 1 .14)% respectively ,and the difference was statistically significant (t=6 .46 ,P<0 .05) .Conclusion The expression rate of CD4+ CD25+ T cells in active SLE patients was significantly lower than that of healthy controls ;the expression rate of CD4+CD25+ T cells in SLE patients increased significantly after treatment .The TGP treatment may work on CD4+CD25+ T cells .